Thursday, June 20, 2013

The display and use of drug information on this site is subject to express terms of use (click here). By continuing to view the drug information, you agree to abide such terms of use.

Velaglucerase Alfa IV Dosage and Storage


IMPORTANT NOTE: The following information is intended to supplement, not substitute for, the expertise and judgment of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that use of the drug is safe, appropriate or effective for you. Consult your healthcare professional before using this drug.

Generic Name: VELAGLUCERASE ALPHA - INJECTION
Pronounced: (VEL-a-GLOO-ser-ase Al-fa)

Velaglucerase Alfa IV Overdose

If overdose is suspected, contact a poison control center or emergency room immediately. US residents can call the US National Poison Hotline at 1-800-222-1222. Canada residents can call a provincial poison control center.

Velaglucerase Alfa IV Missed Dose

For the best possible benefit, it is important to receive each scheduled dose of this medication as directed. If you miss a dose, contact your doctor to establish a new dosing schedule. Do not double the dose to catch up.

Velaglucerase Alfa IV Notes

Laboratory and/or medical tests (such as IgG antibodies) should be performed periodically to monitor your progress or check for side effects. Consult your doctor for more details.

Velaglucerase Alfa IV Storage

Not applicable. This medication is given in a hospital or clinic and will not be stored at home.



CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.
Information last revised May 2010 Copyright(c) 2010 First DataBank, Inc.